The administration (20 mg/kg/day) to diet-induced obesity mice was able to reduce decrease fasting blood glucose (FBG) and insulin levels, and enhanced glucose tolerance and insulin sensitivity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.